Member Info for mazik

The current Coronavirus outbreak has led to a significant increase in the volume of critical medical imaging studies, with chest X-rays and CT scans being key aids to diagnose and manage patients with Coronavirus. In addition to Radiologists, other frontline clinicians will take a central role in reviewing the growing Coronavirus . Great future in front as the short termers are out , this will be rerated accordingly..

Feedback's flagship imaging-based communication platform, will be rolled-out across the Pennine Acute Hospitals NHS Trust with immediate effect as a key patient management tool to assist its coronavirus response. Most likely it will get CE approval and this will be rerated accordingly and will see the last of single figure.. IMO

Feedback's flagship imaging-based communication platform, will be rolled-out across the Pennine Acute Hospitals NHS Trust with immediate effect as a key patient management tool to assist its coronavirus response.

For long term Bleepa is the way forward

John agree with you this is start of the journey, and we are ahead of the game. We are already in UK at Oxford working on a Vaccine to cure this deadly Virus , Goverment funding is available for both the vaccine and the delivery system .Anxious to see what's in front of us...certainly not a market cap of 10m we are talking 100 million plus...GLA, please listen to Nigel's presentation someone posted on this thread.

MRNA market cap is 13 billion already on phase 1 trial on human on coved19 vaccine, our vaccine delivery system will be a small change for them to get the licence for Nuvec...draw your conclusion its likely n4p will be taken over...as the race against time is on force..rumour is that Curevac's independence was on stake in US. We are being looked by national institute of health USA...interesting times..gla

Firm and strong, feel the trend will continue until the AGM of the 23rd, also update on results with Evotec in the coming 8 weeks if not sooner.

This will continue to be rerated as N4p is not a hype its a reality working on vaccine delivery system Nuvec for the last 3 years now its being endorsed by NIH and Evotec imo

deramper ...yes, many wished they did not buy at 19p this morning

Applebee agree it closed up only 32% on Nasdaq and at Aim 126%. Was the frenzy in 2 hours here justified?

Working with NIH USA and Evotec does reassures the credibility of our Vaccine delivery system Nuvec , Evotec offers services and alliances based on its state-of-the-art technology platform and a broad range of integrated capabilities spanning the drug discovery process. Evotec differentiates itself based on a strong track record in drug discovery, scientists with many years experience in the industry and an innovative technology platform".

£36 k 500k buy this morning cannot go unnoticed .

Leister agree with u, A great move for us its opportunity to hold and add for a reward multiples of where we stand, feel that we might be taken over as they are working for novel vaccine delivery system and feel N4P will be rerated accordingly.

Evotec and MIH USA endorsement to work for Vaccine delivery system as N4p's Nuvec is enormous future for us shareholders IMO

A great RNS all heavy weight involved "The Company has received delivery of the initial quantity of the Covid-19 plasmid DNA from the National Institute for Health ("NIH") in the USA and has appointed Evotec International Gmbh ("Evotec") to undertake the Nuvec® proof of concept work for use with Covid-19 at its site in Toulouse, France."

Terrier u can bark, but MIH USA is involoved , see this moving towards multiples IMO

Avion to fund £25 million towards Lupozer phase 3 trial on completion Imm to get £70 million milestone payment...market has realised it's underpriced IMO

True its got it brakes, expecting to rerate on a update ..imo

Mibo did u mean me..... well my 850k looks safe at .26....not a deramper staying firm after thursday's rise was a buy signal

Helu0104....I am here , well done its holding firm so a buy f is a must....